Aimei Health Technology (AFJKR) Cash from Financing Activities (2025)

Aimei Health Technology (AFJKR) reported Cash from Financing Activities of $546950.0 for Q3 2025, down 15.4% quarter-over-quarter from $646543.0 in Q2 2025.

Aimei Health Technology (AFJKR) Cash from Financing Activities (2025) Analysis & Trends

Aimei Health Technology (AFJKR) has 1 years of Cash from Financing Activities data on file, last reported at $546950.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -
2 Berto Acquisition 312.46 Mn 312.46 Mn - -250,000.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -43,625.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 500,000.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -13,092.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - -
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 1.27 Mn
9 BTC Development 262.16 Mn 262.16 Mn - -
10 Aimei Health Technology - - - 546,950.00

Historic Data

Download Data
DateValue
Sep 30, 2025 546,950.00
Sep 30, 2025 546,950.00
Jun 30, 2025 646,543.00
Jun 30, 2025 646,543.00
Mar 31, 2025 -30.58 Mn
Mar 31, 2025 -30.58 Mn